photo de profil d'un membre

Carole ROBIN

Summary

Skills: Regulatory Affairs, Clinical Research, Risk and Projects Management (PMI), Audit in Healthcare companies (drugs, medical devices, cells therapy products), Quality & Environment Management.

Professional experiences

Head of clinical dpt

Eurofins E&E France

Since 2. april 2024

Co-chair leadership team lng france

Regulatory Affairs Professionals Society (RAPS)

Since 2. january 2023

Gmed trainer, clinical evaluation & investigation training

GMED

From September 2021 to August 2024

Board member association la roche (mission: psychic disability support)

Association La Roche

Since 2. july 2021

Director clinical & regulatory - chairman & founder

CR MED CONSULTING

From February 2021 to August 2024

Having earned a Doctorate in Pharmacy and an MSc in Quality, I have a passion for public healthcare.
Prior experience was working for Japanese, US-based, and French companies dealing with medical devices, drugs, and cells therapy products for over 30 years. As RA International Director in previous experiences, I have developed, implemented, and maintained regulatory strategies and guidance based on international requirements for all classes of medical devices.
I also have experience in Quality in establishing, maintaining ISO13485 (audits, inspections) and in Clinical Research where I was responsible for managing more than 20 international clinical trials.
I have been actively involved in company executive strategy as a Business Board member (over 15 yrs) and member of French (snitem) and European (MedTech Europe) industrial associations,
More recently I was responsible for leading MDR compliance as a Person Responsible for Regulatory Compliance (PRRC) and international registrations.
Today, at CR MED Consulting I am committed to sharing my compliance experience as a Consultant to support healthcare companies, train in Clinical and Regulatory activities (GMED contract teacher) and to participating actively in AFAR, RAPS, and Team-PRRC Associations.

Director of regulatory affairs

THUASNE

From January 2019 to December 2020

- Member of the Business Board
- Develop, maintain regulatory strategies and product compliance, Technical Documentation (STED) of medical devices according to Medical Device Regulation (MDR), other international registrations (export), current standards, Eudamed process.
- Develop, maintain strategies of the Post Market (PMS Plan & Report, Promotional material, Vigilance (MIR, IMDRF codification), and Clinical Evaluation processes (CEP, CDP & CER); support to Biological Safety Report, usability, risk management, etc.

Dir. regulatory affairs, clinical & qa

3-D Matrix Europe

From December 2015 to December 2018

Registrations, EC Marking, regulatory strategies for the current and new medical devices (class III implantable, etc.) in relation with Competent authorities and Notify Body. MDD and MDR (2017/745)
QMS (ISO13485:2016, MDSAP) and Vigilance management
Clinical Affairs management and support to Reimbursement (MEDDEV 2.7.1 rev 4)
ansm inspection

International regulatory affairs director

Integra LifeSciences

From June 2014 to November 2015

.Registrations, reimbursement and regulatory strategies in Asia Pacific, Canada, Latin America and EMEA based on International requirements.
.Effective dialogue with Competent regulatory Authorities, Vigilance of Integra product lines (Human Tissue Products (HTP) and Medical Device (MD)).
. Member of the Business Board

Emea director, regulatory & clinical affairs, reimbursement - quality

Integra LifeSciences

From March 2011 to November 2015

Ensure support of the company's business objectives, develop and implement regulatory & reimbursement strategies and guidance in EMEA (Europe, Middle East, Africa). Coordinate all pre- and post- market clinical studies organized on EMEA market for company's products, the EMEA Speakers Bureau

Process coordination, quality & environment director

LABORATOIRES GENEVRIER

From June 2009 to March 2011

- Member of the Business Board
- Clinical Research Director

- Development process and portfolio management
Set up an Integrated Portfolio Mgmt Process
- Quality & Environment

R&d quality evaluation, global manager

BIOMERIEUX

From February 2007 to November 2008

management of the R&D process indicators and metrics (worldwide) in order to measure the performance
internal audit and supplier audit
...

Associations

La Roche

https://laroche.asso.fr/

Membre Conseil Administration

Degree

Skills

Clinical Research
Medical Devices
Regulatory Affairs
Quality Management
Quality Assurance
Clinical Trials
Pharmaceuticals
Quality Systems
Risk Management
GCP
Process Improvement
ISO 13485
Auditing
Compliance
CAPA
Pharmaceutical Industry
Quality System
Biotechnology
FDA
R